HIF‐1α expression is frequently increased in solid cancers, including nonsmall cell lung carcinoma (NSCLC), breast carcinoma, and colorectal carcinoma, and the prognosis of patients with HIF‐1α overexpression is very poor.2, 8, 9. The gene discussed is HIF1A; the disease is colorectal carcinoma.